CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery PatientsPRINCETON, N.J., Aug. 31, 2023 -- CytoSorbents Corporation...
Source: marketscreener.com